Utilization of Uterine Manipulator in Abdominal Hysterectomy

Status Completed

Clinical Trial Summary

The investigators aimed to investigate whether the uterine manipulator which is usually utilized in laparoscopic hysterectomy would also be of benefit in preventing postoperative vaginal length and sexual function by facilitating the accurate localization fo the colpotomy site. Patients scheduled for abdominal hysterectomy for benign causes will be randomized into two arms: Group 1 Uterine manipulator arm in which participants received a uterine manipulator during the procedure for aiding to locate the accurate colpotomy site and Group 2 consisting of control patients who will not receive uterine manipulator but undergo a standard abdominal hysterectomy. Postoperative vaginal length, postoperative female sexual function index (FSFI) will be compared with the preoperative measurements in the two groups. A 5 points Surgeon satisfaction scale will also be applied to the surgeons and residents performing the surgery to address their satisfaction in locating the colpotomy site.

Clinical Trial Description

The uterine manipulator is a device that facilitates to locate the colpotomy site and visualization of surgical are during laparoscopic hysterectomy. The investigators consider that adoption of the uterine manipulator will also facilitate to locate the colpotomy site in abdominal hysterectomy. Therefore the investigators are planning to enroll patients undergoing an abdominal hysterectomy in this study. Patients will be allocated into one of the study groups: Group 1 Uterine manipulator arm in which participants received a uterine manipulator during the procedure for aiding to locate the accurate colpotomy site and Group 2 consisting of control patients who will not receive uterine manipulator but undergo a standard abdominal hysterectomy. All abdominal hysterectomies will be carried out by the same surgeon under general anesthesia. One week before the surgery vaginal length will be measured and the female sexual function index (FSFI) will be obtained from all patients. Following the surgery vaginal length will again be measured at 3 months and the female sexual function index (FSFI) will be obtained from participants by a research staff who is also a gynecologist. Prevalence of postoperative dyspareunia will be asked to the patients at postoperative 3 months. Just after the surgery, a 5 points surgeons' satisfaction scale will also be completed by the surgeons and residents performing the surgery to address their satisfaction in locating the colpotomy site either with the uterine manipulator as in group 1 or by manually guiding as in group 2. ;

Study Design

Related Conditions & MeSH terms

Sexual Dysfunctions, Psychological
Sexual Function Disturbances

Clinical Trial Details

NCT number	NCT03943485
Study type	Interventional
Source	Kanuni Sultan Suleyman Training and Research Hospital
Contact
Status	Completed
Phase	N/A
Start date	May 5, 2017
Completion date	May 20, 2019

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT05072158` - Pelvic Floor Disorders Among Sexual Minoritized Women
Recruiting	`NCT05312320` - Improving Sexual Function After Myocardial Infarction	N/A
Completed	`NCT05561972` - The Ultrasonographic Assessment of Efficacy of Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause	N/A
Completed	`NCT06231433` - Effects of Fractional CO2 Laser Treatment on Vaginal Symptoms and Sexual Dysfunction in Women With Systemic Sclerosis	Phase 2/Phase 3
Recruiting	`NCT05698576` - TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer	N/A
Recruiting	`NCT06028009` - PRP Injections for Genitourinary Syndrome of Menopause	N/A
Not yet recruiting	`NCT06017128` - Sexual Counseling's Impact on Hip Replacement Patients' Sexual Function and Quality of Life: A PLISSIT Model Study	N/A
Completed	`NCT04420533` - Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB Symptoms	N/A
Completed	`NCT05964608` - The Effect of Behavioral Therapy Given to Men and Their Partners'	N/A
Completed	`NCT03194997` - Pilates and Dance to Breast Cancer Patients Undergoing Treatment	N/A
Completed	`NCT04752241` - Preservation of Inferior Mesenteric Artery Could Improve Sexual Function After Laparoscopic Colorectal Resection for Diverticular Disease	N/A
Completed	`NCT05707429` - Sexual Function and Quality of Life Among Patients Suffering From Inflammatory Bowel Disease(Inactive Stage)
Completed	`NCT04923217` - Quality of Life and Sexual Function in Vaginal Aplasia Patients After Davydov Procedure
Completed	`NCT03571841` - Sexual Health and Rehabilitation After Ovarian Suppression Treatment	N/A
Recruiting	`NCT05342090` - Postoperative Return to Sexual Activity	N/A
Recruiting	`NCT03087565` - Urinary and Sexual Functions After Subtotal Versus Total Abdominal Hysterectomy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.